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Ubiquitin chains of different topologies trigger
distinct functional consequences, including protein
degradation and reorganization of complexes. The
assembly of most ubiquitin chains is promoted by
E2s, yet how these enzymes achieve linkage speci-
ficity is poorly understood. We have discovered
that the K11-specificUbe2S orients the donor ubiqui-
tin through an essential noncovalent interaction that
occurs in addition to the thioester bond at the E2
active site. The E2-donor ubiquitin complex tran-
siently recognizes the acceptor ubiquitin, primarily
through electrostatic interactions. The recognition
of the acceptor ubiquitin surface around Lys11, but
not around other lysines, generates a catalytically
competent active site, which is composed of resi-
dues of both Ube2S and ubiquitin. Our studies sug-
gest that monomeric E2s promote linkage-specific
ubiquitin chain formation through substrate-assisted
catalysis.INTRODUCTION
By regulating protein stability, activity, or localization, ubiquitina-
tion exerts control over almost every cellular process. As this
includes pathways responsible for the duplication and separa-
tion of genetic material, aberrant ubiquitination often results in
tumorigenesis. Despite the importance for cellular regulation,
the mechanisms determining the specificity and efficiency of
ubiquitination reactions are still incompletely understood.
Ubiquitination requires at least three enzymatic activities. An
E1 enzyme forms a thioester between a cysteine at its active
site and the C terminus of ubiquitin (Schulman and Harper,
2009). The activated ubiquitin is transferred to a cysteine of an
E2 (Ye and Rape, 2009). In the third step, the charged E2 coop-
erates with E3s to catalyze formation of an isopeptide bondbetween the C terminus of ubiquitin and the 3-amino group of
a substrate lysine (Deshaies and Joazeiro, 2009). The 600
human RING-E3s interact with E2s and substrates at the same
time, allowing them to promote the transfer of ubiquitin directly
from the E2 to the substrate.
The modification of a substrate with a single ubiquitin usually
leads to changes in protein interactions (Dikic et al., 2009). In
many cases, additional ubiquitin molecules are attached to
a substrate-linked ubiquitin, giving rise to polymeric ubiquitin
chains. Such chains can be connected through the N terminus
of ubiquitin or through one of its seven Lys residues, and all link-
ages have been detected in cells (Ye and Rape, 2009; Xu et al.,
2009). Ubiquitin chains of different topologies can have distinct
structures and functions (Dikic et al., 2009; Matsumoto et al.,
2010). K48-linked chains, for example, drive protein degrada-
tion, whereas K63-linked chains regulate the assembly of protein
complexes (Ye and Rape, 2009). Thus, the efficiency and spec-
ificity of chain formation have profound consequences for the
modified protein.
We recently identified K11-linked ubiquitin chains as critical
cell-cycle regulators in human cells (Jin et al., 2008). Most
K11-linked chains are synthesized during mitosis by the E3
anaphase-promoting complex (APC/C) and its E2s Ube2C/
UbcH10 and Ube2S (Williamson et al., 2009; Matsumoto et al.,
2010; Wu et al., 2010). Together, these enzymes modify mitotic
regulators, such as cyclin B, securin, or HURP, to trigger their
degradation (Jin et al., 2008; Song and Rape, 2010). As a result,
inhibiting the formation of K11-linked chains blocks mitotic
progression in Xenopus, Drosophila, and humans (Jin et al.,
2008; Williamson et al., 2009; Garnett et al., 2009), whereas their
untimely assembly causes inaccurate cell division and tumori-
genesis (Wagner et al., 2004; Jung et al., 2006). How the
APC/C and its E2s assemble K11-linked chains, however, is
poorly understood.
Linkage between two ubiquitin moieties involves the covalent
connection of one ubiquitin, the donor, to the active site
cysteine of the E2, followed by nucleophilic attack by a lysine
of an acceptor ubiquitin (Figure 1A). Much of our knowledge
about the basis of linkage specificity is limited to the E2Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc. 769
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Figure 1. Ube2S Recognizes the Hydrophobic Patch of Donor Ubiquitin
(A) Overview of K11-specific linkage formation. Lys11 of acceptor ubiquitin attacks the thioester bond between Cys95 of Ube2S and the C terminus of the donor
ubiquitin.
(B) Ube2S interacts with ubiquitin noncovalently. Weighted combined chemical shift perturbations, Dd(1H15N), are plotted over residue number. The asterisk
indicates the disappearance of the resonance for His68 of ubiquitin in the presence of Ube2S due to intermediate exchange.
(C) Mutation of the hydrophobic patch in ubiquitin interferes with formation of K11-linked ubiquitin dimers (ubiubi) by Ube2S, as monitored by Coomassie
staining.
(D) Ube2S and APC/C extend ubiquitin chains on a fusion between ubiquitin and cyclin A (Ub-L-cycA), as analyzed by autoradiography.
(E) The hydrophobic patch of ubiquitin is required for chain elongation by APC/CCdh1 and Ube2S, as analyzed by autoradiography.
(F) The hydrophobic patch is not required on acceptor ubiquitin. Ube2S was mixed with acceptor His6ubiquitinDGG mutants (ubiDGG; purple) and WT-ubiquitin
(blue) and analyzed by a-ubiquitin-western.
(G) The hydrophobic patch is required on the donor ubiquitin. Ube2S was mixed with WT-ubiDGG and ubiquitin mutants and analyzed by a-ubiquitin-western.
See also Figure S1.Ube2N-Uev1A (Ubc13-Mms2; VanDemark et al., 2001). In this
system, the catalytically inactive Uev1A orients the acceptor
ubiquitin, such that Lys63 of the acceptor is at the active site
of Ube2N charged with the donor (Eddins et al., 2006). In
contrast, K11- and K48-linkage-specific E2s promote chain
elongation in reconstituted systems lacking UEVs (Li et al.,
2009; Pierce et al., 2009; Williamson et al., 2009). Although
kinetic analyses suggest that these E2s also engage acceptor
ubiquitin residues (Petroski and Deshaies, 2005; Rodrigo-Brenni
et al., 2010), the molecular details of acceptor recognition by
monomeric E2s and its importance for linkage-specific chain
formation have not been established.
Here, we have combined functional studies with nuclear
magnetic resonance (NMR) and computational docking to
dissect the mechanism of linkage-specific chain formation by
single-subunit E2s.Weshow that theK11-specificUbe2Sorients
the donor ubiquitin by a noncovalent interaction that is in addition770 Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc.to the flexible covalent linkagebetween thesemolecules at theE2
active site. We find that a similar tethering mechanism is used by
other E2s independently of linkage specificity. The Ube2S-donor
ubiquitin complex transiently engages the acceptor ubiquitin
through electrostatic interactions. As indicated by our analysis,
only binding of the acceptor surface around Lys11, but not
around other lysines, leads to formation of a catalytically
competent active site composed of residues of both Ube2S
and ubiquitin. Hence, linkage-specific ubiquitin chain formation
by Ube2S is the result of substrate-assisted catalysis.
RESULTS
A Noncovalent Interaction with Ubiquitin Is Required
for Ube2S Activity
In the absence of the APC/C, Ube2S generates K11-linked ubiq-
uitin dimers (ubi2) and chains attached to Lys residues of its UBC
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Figure 2. Noncovalent Donor Ubiquitin Binding Is Required for Ube2S Activity
(A) Identification of Ube2S residues involved in noncovalent binding of ubiquitin. Weighted combined chemical shift perturbations,Dd(1H15N), are plotted over the
residue number.
(B) Donor binding is required for formation of ubi2 dimers (ubiubi) by Ube2S mutants, as analyzed by Coomassie staining.
(C) Donor binding by Ube2S is required for chain elongation on Ub-L-cycA with APC/C, as analyzed by autoradiography.
(D) Donor binding by Ube2S is required for chain formation in a full APC/C assay. Ubiquitination of cyclin A by APC/C, Ube2C, and Ube2S mutants was analyzed
by autoradiography.
(E) Donor binding is required for Ube2S activity in vivo. HeLa cell lines expressing Ube2S or Ube2SI121A were treated with siRNAs against the 30 UTR of Ube2S,
which specifically depletes endogenous Ube2S. Cells were synchronized in prometaphase (t = 0 hr) or late mitosis (t = 2 hr), and K11-linked ubiquitin chains were
detected by aK11-western.
(F) Donor binding occurs in cis. Ube2SC118A or Ube2SI121A (lack the noncovalent ubiquitin-binding site) and Ube2SC95A (no active site) were mixed, and ubi2
formation was monitored by Coomassie staining.
See also Figure S2.domain and its C-terminal tail (Figure S1A available online). The
UBC domain of Ube2S (UBCUbe2S) promotes ubi2 formation
with similar kinetics and specificity as Ube2S (Figure S1A). Like
Ube2S, UBCUbe2S is monomeric in ubiquitination buffers, as sug-
gested by gel filtration, small-angle x-ray scattering (SAXS), and
other biophysical techniques (Figures S1B and S1C; data not
shown). Thus, UBCUbe2S contains all elements required for the
synthesis of K11 linkages, making it an appropriate system for
analyzing the mechanism of linkage-specific chain formation.
The prevailingmodel of linkage-specific chain formation posits
that an elongating E2, chargedwith the donor ubiquitin, binds the
acceptor in such a way that a preferred acceptor lysine is at the
E2 active site (Eddins et al., 2006). To test for such a noncovalent
interaction between Ube2S and ubiquitin, we performed
titrations of 15N-enriched ubiquitin with Ube2S and UBCUbe2S,respectively, and monitored 1H-15N HSQC spectra. The pres-
ence of either E2 caused significant resonance-specific chemi-
cal shift perturbations in the ubiquitin spectrum, indicating
a specific interaction (Figure 1B).
Chemical shift mapping on the surface of ubiquitin revealed
that the hydrophobic patch surrounding Ile44 is involved in the
noncovalent interaction with Ube2S (Figure S2B). Mutation
of the isoleucine to alanine (ubiI44A) disrupted the interaction
with Ube2S (Figure 1B and Figure 2A). Furthermore, mutating
residues in the hydrophobic patch (L8A, I44A, V70A) interfered
strongly with the formation of K11-linked ubi2 by Ube2S
(Figure 1C).
Ube2S extends K11-linked chains on APC/C substrates after
initiation by Ube2C (Williamson et al., 2009; Wu et al., 2010). To
test whethermutations in ubiquitin interferewith chain elongationCell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc. 771
by Ube2S and APC/C, we bypassed the need for Ube2C by
generating a fusion between ubiquitin and the APC/C substrate
cyclin A (Ub-L-cycA). Ube2S and APC/C rapidly elongated ubiq-
uitin chains on Ub-L-cycA, which did not require Ube2C and was
not inhibited by an excess of inactive Ube2CC114S (Figure 1D).
Mutation of the hydrophobic patch of ubiquitin interfered strongly
with this activity of Ube2S (Figure 1E; Figure S1D), without
affecting charging by E1 (Figure S1F). The same mutations in
ubiquitin blocked ubiquitination of APC/C substrates in an assay
containing both Ube2C and Ube2S (Figure S1E). Thus, a nonco-
valent interactionwith ubiquitin is required for the ability of Ube2S
to assemble K11-linked ubiquitin chains.
The Hydrophobic Patch Is Required on the Donor
Ubiquitin
To determine whether Ube2S interacts with donor or acceptor
ubiquitin, we made a ubiquitin mutant lacking its two C-terminal
Gly residues, ubiDGG. ubiDGG is not activated by E1 and can only
act as acceptor. Ube2S produced dimers between ubiDGG and
ubiquitin (ubiDGG-ubi; Figure 1F), and mutation of Lys11 on the
acceptor ubiDGG, but not the donor ubiquitin, blocked this reac-
tion (Figures 1F and 1G). The mutation of Leu8, Ile44, or Val70 on
the acceptor ubiDGG had no effect on the formation of ubiDGG-ubi
dimers (Figure 1F; Figure S1G). Instead, when the hydrophobic
patch was mutated on the donor ubiquitin, dimer formation
was prevented (Figure 1G).
We conclude that Ube2S recognizes the donor ubiquitin.
Several aspects of our analysis indicate that this is the only ther-
modynamically stable interaction between ubiquitin and Ube2S
in solution. The NMR-derived binding isotherms are well
described by a single-site bindingmodel (Figure S2D); significant
chemical shift perturbations map to one contiguous binding
region (Figure S2B); and disruption of the donor interface did
not result in the population of an alternate binding site (Figure 1B).
Variation of the experimental conditions, such as ionic strength
and pH, also did not provide evidence for a second binding
site (data not shown). Thus, Ube2S forms a noncovalent inter-
face with the hydrophobic patch of the donor ubiquitin, which
is required for its activity to promote the formation of K11-linked
ubiquitin chains.
The Donor Ubiquitin Interacts with Helix aB of Ube2S
We identified the donor-binding site on Ube2S by titrating 15N-
enriched UBCUbe2S with ubiquitin and measuring 1H-15N HSQC
spectra. Significant ubiquitin-induced chemical shift perturba-
tions mapped to a surface region around the C-terminal part of
helix aB of Ube2S (Figure 2A; Figure S2B). The same region
was found to interact with covalently bound donor ubiquitin (Fig-
ure S2A). Mutation of two Ube2S residues in this region (C118A,
I121A) impaired ubiquitin binding (Figure 2A; Figure S2C) without
affecting the structural integrity of Ube2S (data not shown). The
dissociation constant (KD) for this interaction (1.11 ± 0.08 mM or
1.7 ± 0.08 mM for ubiquitin binding to UBCUbe2S or Ube2S; Fig-
ure S2D) was comparable to the estimated concentration of
donor ubiquitin linked to the Ube2S active site (3 mM; Petroski
and Deshaies, 2005). Our results, therefore, suggest that cova-
lently linked donor ubiquitin occupies the noncovalent binding
site on Ube2S around helix aB.772 Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc.Based on our previous results, we expected the donor inter-
face of Ube2S to be required for activity. Indeed, Ube2SC118A
and Ube2SI121A were strongly impaired in ubi2 formation (Fig-
ure 2B); K11-linked chain assembly on Ub-L-cycA with APC/C
(Figure 2C); or modification of cyclin A in an APC/C assay con-
taining Ube2C and Ube2S (Figure 2D). Disrupting this Ube2S
surface did not affect charging by E1 (Figure S2E) or binding to
the APC/C (Figure S2F).
To test for the importance of donor binding at physiological
ubiquitin levels, we generated HeLa cell lines that stably express
Ube2S or Ube2SI121A. Endogenous Ube2S was specifically
depleted from cells by siRNAs against the 30 untranslated region
(UTR) of the Ube2S mRNA, and formation of K11-linked chains
was monitored upon exit from mitosis by a K11-linkage-specific
antibody. As expected, long K11-linked chains were absent from
cells lacking Ube2S, whichwas rescued by expression of siRNA-
resistant wild-type (WT)-Ube2S (Figure 2E). By contrast, the
donor-binding-deficient Ube2SI121A failed to promote K11-
linked chain formation. Thus, recognition of the donor ubiquitin
by Ube2S is essential for K11-linked ubiquitin chain formation
in vitro and in vivo.
NMR-Based Docking of the Donor Ubiquitin on Ube2S
The binding site for the donor ubiquitin on Ube2S, as defined by
chemical shift mapping, makes it plausible that this interaction
occurs in cis, i.e., involves the same E2 that the donor is cova-
lently attached to. To test this idea, we determined whether
a catalytically inactive Ube2S mutant with an intact donor-
binding site (Ube2SC95A) could complement the loss-of-function
phenotype of a Ube2S mutant with a defective noncovalent
interface (Ube2SC118A, Ube2SI121A). As this was not the case
(Figure 2F), the observed noncovalent interaction most likely
occurs in cis.
To obtain a structural model of the interaction between
UBCUbe2S and donor ubiquitin, we used the docking program
HADDOCK (de Vries et al., 2007). The NMR chemical shift data
were used to specify residues at the interface, and we defined
only one explicit distant restraint that required the C-terminal
carbon atom of Gly76 of ubiquitin to be close to the Sg atom of
Cys95 in Ube2S. HADDOCK produced an ensemble of 200
structures after automated refinement, which were clustered
using a backbone root-mean-square deviation (rmsd) cut-off of
7.5 A˚. The resulting three clusters contain 71%, 25.5%, and
2.5% of all docked models, respectively (Table S1). As shown
later, structures in cluster 1, but not those of clusters 2 and 3,
could be validated by biochemical data.
As a representative structure of the Ube2S-donor ubiquitin
complex, we selected a model from cluster 1 that among the
top 3 according to HADDOCK scoring had the largest buried
surface area, the most negative interaction energy, and the
smallest number of distant restraint violations (Figure 3A;
Table S1). A similar model with a low backbone rmsd of
1.1 A˚ was obtained by a different docking program, Cluspro
(Comeau et al., 2007), without restraints (Figure S3A). Our
model resembles the structure of the charged E2 Ubc9, when
bound to its E3 (Reverter and Lima, 2005), and an NMR-based,
docked model of the E2 Ubc1 and ubiquitin (Hamilton et al.,
2001).
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Figure 3. Structural Model of the Ube2S-Donor Ubiquitin Complex
(A) NMR-based HADDOCKmodel of the UBCUbe2S-donor ubiquitin complex (cluster 1, no. 3; see Table S1). The C-terminal tail of ubiquitin (cyan) was allowed full
flexibility during docking.
(B and C) Surface representation of the binding interface on UBCUbe2S (B) and donor ubiquitin (C). Residues that make intermolecular contacts within a radius of
4 A˚ are shown in pink.
(D) Ube2S residues at the donor-binding interface are required for formation of ubi2 dimers (ubiubi), as monitored by Coomassie staining.
(E) Donor-binding-deficient Ube2S mutants do not promote chain elongation on Ub-L-cycA with APC/C, as analyzed by autoradiography.
(F) Ubiquitin residues at the Ube2S interface are required for linkage formation, as seen by Coomassie staining.
(G) Ubiquitin residues at the Ube2S interface are required for chain elongation on Ub-L-cycA with APC/C, as analyzed by autoradiography.
(H) Donor binding is required for Ube2S activity in cells. HeLa cell lines expressing donor-binding-deficient Ube2S (E51K; D102A; S127A) were depleted of
endogenous Ube2S, synchronized in prometaphase (t = 0) or allowed to exit mitosis (t = 2 hr), and tested for K11-linked ubiquitin chains by aK11-western.
(I) Charge-swap analysis of the ionic interaction between Lys6 of donor ubiquitin and Glu51 on Ube2S. ubiDGG was mixed with ubiquitin or ubiK6E in the presence
of Ube2S or Ube2SE51K. Reactions were monitored by Silver staining.
See also Figure S3 and Table S1.Within our model, the donor ubiquitin docks onto a hydro-
phobic area on Ube2S, comprising the C-terminal half of helix
aB, theC-terminal part of helixaC,and theN-terminal part of helix
aD (Figures 3Aand3B). The corresponding interaction surfaceon
donor ubiquitin contains the hydrophobic patch (Figure 3C),
which is extended to form a contact area that buries a total of
830 A˚2 on ubiquitin. Themodel includes ionic contacts between
Lys6, Arg42, and Lys48 of ubiquitin, and Glu51, Glu126, and
Glu142 of Ube2S (Figure S3B). An ionic contact between
Arg74 of ubiquitin and Asp102 of Ube2S serves as a linchpin to
guide the C terminus of ubiquitin toward the active site of
Ube2S (Figure S3C). The ubiquitin tail is also anchored by
hydrogen bondsbetween the peptide backbone andUbe2S resi-
duesclose to the active site. Thedistancebetween theSgatomof
Cys95 of Ube2S and the C-terminal carbon atom of ubiquitin,
3.9 A˚, is too long for a covalent bond, but small adjustments
around the active site of Ube2S could readily close this gap.Validation of the Ube2S-Donor Ubiquitin Model
Based on the selected model for this complex, we designed
additional mutations to test the structural details of the predicted
interface. We found that altering residues at the binding interface
(Ube2S: E51K, R101A, D102A, S127A, Y141A; ubiquitin: K6E,
K48E, T66E, H68A, L71A, R72A) interfered with Ube2S activity
in vitro (Figures 3D–3G) and, as seen for ubiK6E, disrupted the
Ube2S-donor ubiquitin interaction (Figure 2A). Residues that
do not make intermolecular contacts (Ube2S: D29, G30, L114,
E142; ubiquitin: A46) were not required for activity (data not
shown). Introducing mutations into ubiDGG showed that most
ubiquitin residues were required in the donor but not the
acceptor (Figures S3D and S3E). The role of Lys6 in the acceptor
ubiquitin is described below. With the exception of ubiR72A,
no Ube2S or ubiquitin mutant was impaired in charging by
E1 (Figures S3F and S3G). To confirm this analysis in vivo,
we generated cell lines that express Ube2S mutants withCell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc. 773
A B
C
1 2 3 4 5 6 7 8 9 11 13
+UBA
+ UBA
- UBA
W
T-
ub
iq
ui
tin
1 2 3 4
number of ubiquitin molecules in chain
+ UBA
- UBA
+UBA
ub
i-V
70
A
0 5 10 20 30 5 45 5 45 5 45 time (min)
Ub-L-cycA
Ub2-L-cycA
Uboligo-L-cycA
Ubpoly-L-cycA
autoradiography
W
T-
ub
i
ub
i-I
44
A
ub
i-V
70
A
ub
i-I
44
A/
V7
0A
ubiquitin
mutant:
D
Coomassie
longer exposure
ubiquitin
or Ube2S
mutant:
ubi
ubi~ubi
Ube2S
ubi-K11R
WT-ubi
W
T
C1
18
A
I1
21
A
E5
1K
ub
i-I
44
A
Coomassie
25
50
100
150
250
12.5
6.25
200
120100806040200 120100806040200
Silver
time (min)
[ubi ΔG
G] (μM
)
K11R ΔGG K11R
I44A
ΔGG
W
T-
ub
iq
ui
tin
ub
i-V
70
A
0 30 60 90 120
K11R ΔGG
Ube2S A121I-S2ebUS2ebU
Figure 4. Noncovalent Donor Binding Increases the Processivity of Ube2S
(A) Donor binding is not required for the K11-linkage specificity of Ube2S. Ube2S or donor-binding mutants were incubated with ubiquitin or ubiK11R, or as
indicated with ubiI44A and ubiI44A/K11R. Reactions were incubated longer and at higher ubiquitin concentrations to observe formation of ubi2 and analyzed by
Coomassie staining.
(B) Donor binding promotes catalysis at low acceptor concentrations. Dimer formation between increasing levels of ubiDGG and ubiK11R or ubiK11R/I44A,
respectively, by Ube2S was monitored by Silver staining.
(C) Time-course analysis of chain elongation on Ub-L-cycA by APC/CCdh1 and Ube2S in the presence of ubiquitin mutants, as analyzed by autoradiography.
(D) Donor binding is required for processive chain formation by Ube2S. Chain elongation on Ub-L-cycA by APC/C and Ube2S was monitored in the presence of
the UBA domains of Rad23A. Reactions were performed with ubiquitin or ubiV70A and analyzed by autoradiography (top) and line scanning (bottom).defective donor-binding interfaces (E51K; D102A; S127A).
Importantly, all of these failed to promote the formation of K11-
linked ubiquitin chains in HeLa cells that lacked endogenous
Ube2S (Figure 3H).
To further test our model, we used charge-swap analysis to
analyze the role of the predicted ion pair between Glu51 of
Ube2S and Lys6 of ubiquitin. While the K6E mutation in donor
ubiquitin interfered with formation of ubiDGG-ubi dimers, this was
rescued by a complementary mutation in Ube2S, Ube2SE51K
(Figure 3I). Ube2SE51K did not establish ubi2 formation for other
ubiquitin mutants, such as ubiI44A, attesting to the specificity of
this rescue (Figure S3H). Together, the mutational studies,
charge-swap analysis, and in vivo experiments validate the774 Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc.selected NMR-basedmodel for the Ube2S-donor ubiquitin inter-
action and show its importance for chain formation by this E2.
Noncovalent Donor Ubiquitin Binding Is Required
for Processive Chain Formation
We next determined the role of donor binding for catalysis by
Ube2S. It was unlikely that recognizing the donor ubiquitin was
important for specificity, and indeed, any ubi2 formed in the pres-
ence of ubiI44A was lost upon mutation of K11 (Figure 4A). The
same was observed when Ube2S mutants with a defective
donor-binding interface (Ube2SI121A; Ube2SC118A; Ube2SE51K)
were analyzed for ubi2 formation (Figure 4A). Thus, donor binding
does not determine the K11 specificity of Ube2S.
Alternatively, the noncovalent interaction between the donor
and Ube2S might prevent a flexible donor molecule from inter-
fering with acceptor recognition. If this is the case, higher
concentrations of the acceptor ubiDGG should rescue the defect
in ubi2 formation when the Ube2S-donor ubiquitin interface is
disturbed. Consistent with this hypothesis, high levels of ubiDGG
allowed linkage formation with ubiI44A or Ube2SI121A (Figure 4B).
The acceptor concentration required under these conditions was
above the endogenous ubiquitin levels in HeLa cells (90 mM) (Ryu
et al., 2006), consistent with the lack of Ube2SI121A activity
in vivo. These findings suggest that noncovalent binding of the
donor ubiquitin facilitates acceptor recognition by Ube2S.
Based on these observations, we expected that donor binding
would increase the processivity of chain formation by Ube2S.
Indeed, a time-resolved analysis of chain elongation on Ub-
L-cycA suggested that Ube2S assembles chains with high
processivity (Figure 4C), whereas chain formation occurred in
a step-like, distributive fashion if donor-binding was impaired
(Figure 4C). To directly measure the processivity of chain elonga-
tion, we supplied the reactions with a UBA domain. As previously
described (Rape et al., 2006), the UBA domain captures any
substrate dissociating from the APC/C, thereby preventing it
from rebinding the E3 and revealing the number of ubiquitin
molecules transferred in a single substrate-binding event.
Ube2S could transfer up to 13 ubiquitin molecules to Ub-L-
cycA per binding event (Figure 4D, top), whereas less than four
molecules of the hydrophobic patch mutant ubiV70A were trans-
ferred (Figure 4D, bottom). As this UBA domain only recognizes
K11-chains with at least 5 ubiquitin moieties (data not shown),
the number of ubiV70A molecules transferred in a single binding
event is likely even smaller. Thus, the noncovalent interaction
between Ube2S and donor ubiquitin increases the processivity
of chain formation, at least in part by facilitating acceptor ubiqui-
tin recognition.
Noncovalent Donor Ubiquitin Binding Is a Feature
of Chain Elongation in Other E2s
To test whether other E2s bind the donor ubiquitin noncova-
lently, we turned to Ube2R1 and Ube2G2, which extend K48-
linked chains (Li et al., 2009; Pierce et al., 2009). Disruption of
the hydrophobic patch on ubiquitin strongly impaired the forma-
tion of K48 linkages by these E2s (Figure S4A), while having no
effect on their charging by E1 (Figure S4B). Analogous to our
results for Ube2S, we found that the activity of Ube2R1 and
Ube2G2 was dependent on recognition of the hydrophobic
patch on the donor but not the acceptor ubiquitin (Figure 5A).
As revealed by ubiI44A/K48R- and ubiV70A/K48R-double mutants,
noncovalent donor binding did not determine linkage specificity
(Figure 5B) but was required for catalysis at low substrate
concentrations (Figure 5C).
To test whether a common E2 surface recognizes the donor
ubiquitin, we studied Ube2R1 mutations of sites that are struc-
turally homologous to the Ube2S-donor interface (Figure 5D).
These mutations (Ube2R1T122E; Ube2R1L125A; Ube2R1I128E)
strongly inhibited the formation of K48 linkages (Figure 5D; Fig-
ure S4C), without affecting charging by E1 (Figure S4D). The
samemutations also impaired the SCF- and Ube2R1-dependent
formation of ubiquitin chains on IkBa (Figure 5E). Thus, similarsurfaces on the conserved E2 fold and ubiquitin are used for
chain elongation by E2s of different linkage specificity. The teth-
ering of the donor ubiquitin by an E2, therefore, provides
a conserved mechanism to facilitate acceptor recognition.
Ube2S Recognizes the TEK-Box in Acceptor Ubiquitin
We next identified the binding site for the acceptor ubiquitin on
Ube2S. Consistent with previous analyses (Petroski and
Deshaies, 2005; Rodrigo-Brenni et al., 2010), acceptor binding
was too transient to be detected by NMR, independently of
whether the donor ubiquitin had been linked to the Ube2S active
site or not (data not shown). We therefore used HADDOCK to
dock a second ubiquitin molecule, the acceptor, onto the vali-
dated Ube2S-donor ubiquitin complex. The only restraint used
for this docking defined the Nz-atom of the acceptor Lys11 to
be close to the Sg atom of Cys95 at the Ube2S active site.
HADDOCK generated two clusters ofmodels, whichwere similar
in terms of energy and buried surface area (Figure S5; Table S2).
Intriguingly, models in cluster 1 orient the TEK-box of ubiquitin
toward the active site of Ube2S. The TEK-box is a surface region
of ubiquitin that was previously identified to mediate the prefer-
ence of Ube2C/UbcH10 for assembling K11-linked chains (Jin
et al., 2008). We found that mutation of the TEK-box strongly
interfered with the ability of Ube2S to synthesize K11-linked
ubi2 (Figure 6A), to elongate chains on Ub-L-cycA (Figure 6B),
and to modify cyclin A in a full APC/C assay (Figure S6A). Resi-
dues outside of the TEK-box (Thr9, Glu16, Lys33) were not
required for activity (data not shown). Introducing mutations
into ubiDGG revealed that the TEK-box was essential on the
acceptor (Figure 6C) but, with exception of Lys6, not the donor
ubiquitin (Figure 6D). The TEK-box was dispensable for Ube2S
charging by E1 (Figure S6B) or binding of donor ubiquitin to
Ube2S (Figure S6C). Thus, the TEK-box of the acceptor ubiquitin
is required for K11-linkage formation by Ube2S.
On the basis of these results, we performed another docking
run that defined four TEK-box residues to be at the interface
(Table S2). All HADDOCK solutions grouped into a single cluster
reproducing the binding topology of cluster 1 of the previous run
(Figure 6E). With backbone rmsd values of1 A˚, the bestmodels
of this ensemble were remarkably similar, and we focused on the
top-scoring model (cluster 1, no. 1; Table S2, bottom).
In this model of the ternary complex, the acceptor ubiquitin
interacts mostly with Ube2S (Figure 6E), with a total buried
surface area between the acceptor ubiquitin and the Ube2S-
donor complex of 980 A˚2 (Figures 6F and 6G). The acceptor
ubiquitin uses its b strand region to bind a surface of Ube2S
comprising the active site helix aCat, the loop region between
helices aB and aC, and helix aC (Figure 6F). Although the inter-
action leads to the burial of few hydrophobic residues, these
are not closely packed, and the interface is predominantly elec-
trostatic. In particular, a network of ionic contacts involving Lys6
andLys63of ubiquitin, Glu131andGlu139 ofUbe2S, and a series
of hydrogen bonds including Glu64 of ubiquitin and Arg135 of
Ube2S are key features of the interface (Figure S6D). The electro-
static Ube2S-acceptor interface is consistent with the low affinity
between these molecules (Sheinerman and Honig, 2002).
Mutating residues in the predicted binding site on Ube2S
(N97A, E131K, R135E), but not outside of this interface (K76,Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc. 775
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(A) Ube2R1 and Ube2G2 require the hydrophobic patch in the donor but not acceptor ubiquitin for K48-linkage formation. Ube2S, Ube2R1, or Ube2G2 and its E3
gp78 were incubated with ubiDGG or ubiDGG/I44A/V70A (purple) and ubiquitin or ubiI44A (blue). Reactions were analyzed by Silver staining.
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(C) Donor binding is required for rapid catalysis by Ube2R1. Time courses of ubi2 formation by Ube2R1 in the presence of increasing concentrations of ubiquitin or
ubiI44A were analyzed by Coomassie staining.
(D) A similar surface as the donor-binding interface of Ube2S (yellow) is required in Ube2R1 (green; PDB ID: 2OB4). Ube2R1 mutants were analyzed for K48-
specific ubi2 formation by Coomassie staining.
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See also Figure S4.N91, E93, K100, E126, E132), impaired production of ubi2 (Fig-
ure 6H; data not shown), chain elongation on Ub-L-cycA
(Figure 6I), and substrate modification in a full APC/C assay (Fig-
ure S6E). As seen in cells expressing Ube2SE131K or Ube2SR135E,
these mutations also inhibited formation of K11-linked chains
in vivo (Figure 6J). Asn97, Glu131, and Arg135 were not required
for Ube2S charging by E1 (Figure S6F) or Ube2S binding to the
APC/C (Figure S2F).
We next probed the predicted ionic contacts between Ube2S
and the acceptor ubiquitin by charge-swap analyses. Our model
found the acceptor Lys6 to face Glu131 of Ube2S (Figure 7A).
Consistent with this, the loss of ubiDGG-ubi formation caused776 Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc.by a K6E mutation in the acceptor ubiDGG could be rescued by
Ube2SE131K or Ube2SE131A (Figure 7A; Figure S7A), but not by
other Ube2S mutants in this interface (N97A, R135E) (Fig-
ure S7B). Thus, the acceptor Lys6 is recognized by Glu131 of
Ube2S, whereas the donor Lys6 contacts Glu51 of Ube2S (Fig-
ure 3); indeed, Ube2SE51K/E131K completely rescued ubi2 forma-
tion by ubiK6E (Figure 7B; Figure S7C). Our model also showed
Arg135 of Ube2S in proximity of Glu64 of ubiquitin. Accordingly,
the diminished activity of Ube2SR135E was significantly rescued
by ubiE64K (Figure S7D), but not other ubiquitin mutants in the
proximity of this surface (Figure S7E). Finally, less ubi2 was
formed in the presence of ubiK63E, which could be rescued by
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Figure 6. Acceptor Ubiquitin Recognition by the Ube2S-Donor Ubiquitin Complex
(A) The TEK-box in ubiquitin is required for K11-linkage formation by Ube2S. Ube2S was incubated with ubiquitin mutants, and ubi2 formation (ubiubi) was
monitored by Coomassie staining.
(B) TEK-box mutants in ubiquitin inhibit chain formation on Ub-L-cycA by Ube2S and APC/C, as analyzed by autoradiography.
(C) The TEK-box is required on acceptor ubiquitin. ubiDGG mutants (purple) were incubated with ubiquitin (blue) and Ube2S and analyzed by Silver staining.
(D) The TEK-box is not required in donor ubiquitin. TEK-box mutants of ubiquitin were mixed with WT-ubiDGG and Ube2S, and reactions were analyzed by
Coomassie staining.
(E) HADDOCK-based model of the ternary complex between the UBCUbe2S (yellow), donor ubiquitin (blue), and acceptor ubiquitin (pink; cluster 1, no. 1; see
Table S2, bottom).
(F) Surface representation of the Ube2S-binding interface on acceptor ubiquitin. Contact residues within a radius of 4 A˚ are shown in pink.
(G) Surface representation of the acceptor-binding interface on the Ube2S-donor complex.
(H) Acceptor binding is required for Ube2S activity. Ube2S mutants were incubated with ubiquitin and analyzed by Coomassie staining.
(I) Ube2S residues at the acceptor interface are required for chain elongation by APC/C. The modification of Ub-L-cycA by APC/C and Ube2S mutants was
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(J) Ube2S residues at the acceptor-binding interface are required in vivo. HeLa cell lines expressing Ube2SE131K and Ube2SR135E were treated with siRNAs to
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See also Figure S5, Figure S6, and Table S2.mutation of the opposing Glu139 of Ube2S (Figure S7F). The
mutational and charge-swap analyses provide strong support
for our model of acceptor recognition by Ube2S.
Linkage Specificity Is Determined by Substrate-
Assisted Catalysis
The low affinity of Ube2S for acceptor ubiquitin raised the ques-
tion of how this E2 achieves the stringent selection of K11 over
other linkages. In one scenario, recognition of other Lys resi-
dues would be even less favored, with differences in binding
energies accounting for the K11 specificity of Ube2S. To
address this issue, we carried out docking calculations that
placed each of the other Lys residues of ubiquitin in proximity
to the active site of charged Ube2S. Among the clusters
returned by HADDOCK, several had buried surface areas andenergy characteristics comparable to our K11-centered model
(Figure S8; Table S3). This suggests that other Lys residues
can be exposed to the active site of Ube2S, yet these binding
events do not result in linkage formation. Thus, selective
acceptor binding is not sufficient to explain the K11 specificity
of Ube2S.
Alternatively, the composition of the active site of Ube2Smight
force the reaction toward K11 linkages. Our models of the
ternary complex found that the active site of Ube2S was similar
to the E2 Ubc9 (Reverter and Lima, 2005; Figure 7C). For Ubc9,
several residues in addition to the active site cysteine were
attributed roles in catalysis: Tyr87 and Asn85 of Ubc9 contribute
to pKa suppression of the substrate lysine through desolvation.
Further, Asn85 serves to stabilize the oxyanion intermediate
during ubiquitin transfer, and Tyr87 provides a hydrophobicCell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc. 777
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Figure 7. Substrate-Assisted Catalysis Contributes to the K11-Linkage Specificity of Ube2S
(A) Charge-swap analysis of the ionic contact between acceptor Lys6 and Glu131 of Ube2S. Ube2S or Ube2SE131K was mixed with ubiDGG or ubiDGG/K6E and
reactions were analyzed by Silver staining.
(B) Ube2SE51K/E131K rescues mutation of Lys6 in both acceptor and donor ubiquitin. Lys6 was mutated in acceptor ubiDGG (purple) or donor ubiquitin (blue), and
ubiDGG-ubi formation by Ube2S or Ube2SE51K/E131K was analyzed by Silver staining.
(C) Ube2S (left) and Ubc9 (PDB ID: 2GRN; right) show similar active site constellations. The highest scoring Ube2S model of the HADDOCK run in the absence of
ambiguous restraints is shown (Table S2, top; cluster 1, no 1).
(D) Candidate active-site residues are required for the activity of Ube2S to catalyze ubi2 formation (ubiubi), as analyzed by Coomassie staining.
(E) Active-site residues in Ube2S are required for chain elongation by APC/C. Ub-L-cycA was incubated with APC/CCdh1 and Ube2S mutants and analyzed by
autoradiography.
(F) Leu129 is required for Ube2S activity in vivo. HeLa cell lines expressing Ube2S or Ube2SL129 were tested for formation of K11-linked chains after endogenous
Ube2S was depleted by siRNAs. K11-chain formation in cells arrested in prometaphase or exiting mitosis was monitored by aK11-western.
(G) Glu34 of acceptor ubiquitin is required for K11-linkage formation. Ubiquitin mutants were incubated with Ube2S and analyzed by Coomassie staining.
(H) Glu34 of acceptor ubiquitin is required for chain elongation by APC/C and Ube2S. The modification of Ub-L-cycA by APC/C, Ube2S, and ubiquitin mutants
was analyzed by autoradiography.
(I) ubiE34Q displays catalytic, but not binding defects. The rates of ubi2 formation at different concentrations of ubiquitin and ubi
E34Q at the indicated pH were
determined from two or three independent time courses. Apparent kinetic constants were obtained by fitting the rate constants to a Michaelis-Menten equation.
(J) Rescue of ubiE34Q, but not other TEK-box or hydrophobic patch mutants, by increasing the reaction pH. Ubiquitin or indicated mutants were incubated with
Ube2S at pH 7.5 (left) or pH 9 (right) and analyzed by Coomassie staining.
See also Figure S7, Figure S8, and Table S3.platform to position the attacking lysine side chain (Yunus and
Lima, 2006). Whereas Asn85 of Ubc9 is conserved in Ube2S
(Asn87) (Figure 7C), the attacking lysine is likely positioned by
Leu129 of Ube2S (Figure 7C). Asn87 and Leu129 are essential
for Ube2S activity in vitro (Figures 7D and 7E) and, as seen778 Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc.with HeLa cell lines expressing Ube2SL129E, in vivo (Figure 7F).
The mutation of Asn87 or Leu129 did not impede charging of
Ube2S by E1 (Figure S7G).
In addition to Asn85 and Tyr87, Asp127 of Ubc9 was assigned
a catalytic role in reducing the pKa of the substrate lysine (Yunus
and Lima, 2006). In Ube2S, this residue is replaced by serine
(Ser127), which our models place into a position to interact
with the donor ubiquitin rather than activate an acceptor lysine
(Figure 3). Strikingly, instead of an E2 residue, our models
show an amino acid of ubiquitin, Glu34, to be in an appropriate
position to orient the acceptor Lys11 and to promote its desolva-
tion (Figure 7C). The mutation of Glu34 inhibited K11-linkage
formation (Figures 7G and 7H), and kinetic analyses found this
to be due to a strong reduction in the apparent catalytic rate
constant (kcat) but not the Michaelis-Menten constant (KM) (Fig-
ure 7I). Thus, a residue in the substrate, Glu34 of ubiquitin, plays
an important role in catalysis by Ube2S.
Due to its position in the ternary complex, Glu34 is expected to
orient Lys11, but not other Lys residues, and to suppress its pKa.
The E34Q mutant of ubiquitin might maintain the position of
Lys11 but fail to promote its deprotonation. If this assumption
is correct, the inability of ubiE34Q to produce ubi2 may be rescued
by increasing the pH of the reaction, which facilitates lysine
deprotonation. Indeed, Ube2S efficiently linked ubiE34Q mole-
cules at higher pH (Figure 7J), which was due to a change
in the apparent kcat, but not KM (Figure 7I). By contrast, an
acceptor TEK-box mutant defective in Ube2S binding (ubiT14E)
and a donor ubiquitin mutant (ubiI44A/V70A) were inactive at
pH 9 (Figure 7J). These findings support the notion that Glu34
of ubiquitin participates in catalysis by suppressing the pKa of
the acceptor Lys11.
As the catalytic role of Glu34 could be bypassed by increasing
the pH, the same treatment might reduce the specificity of
Ube2S. Consistent with this hypothesis, Ube2S modified Lys
residues in a peptide derived from its C-terminal tail much
more efficiently at pH 9 than at pH 7.5 (Figure S7H). Moreover,
at pH 9, but not at pH 7.5, Lys63 and Lys48 of ubiquitin could
act as acceptor for Ube2S (Figure S7I), although the bulk of
linkage formation still occurred through K11 (Figure S7J). These
findings further suggest that Ube2S requires a residue in ubiqui-
tin, Glu34, for specific formation of K11 linkages. We conclude
that Ube2S promotes linkage-specific ubiquitin chain formation
by substrate-assisted catalysis.
Conclusions
K11- and K48-linked ubiquitin chains are often assembled by
single-subunit E2s that cooperate with RING-E3s (Ye and
Rape, 2009). Most of these E2s are specific and processive,
but how these properties are achieved in the absence of cofac-
tors was poorly understood. Here, we addressed this question
by dissecting the mechanism of ubiquitin chain assembly by
the K11-specific E2 Ube2S.
We found that Ube2S requires a noncovalent interaction with
the donor ubiquitin for chain formation. Although the affinity of
Ube2S for the donor ubiquitin is weak, this interaction occurs
in addition to the covalent thioester bond at the E2 active site.
It tethers the donor ubiquitin to the E2, thereby restricting its flex-
ibility and facilitating acceptor recognition. It also places the C
terminus of the donor ubiquitin in an optimal position for nucleo-
philic attack by the acceptor lysine.
The Ube2S-donor ubiquitin complex binds the acceptor ubiq-
uitin very transiently through primarily electrostatic interactions.
Ube2S recognizes the TEK-box on acceptor ubiquitin, a motifpreviously identified as being required for formation of K11 link-
ages by Ube2C (Jin et al., 2008). As seen in crystal structures of
K11-linked ubiquitin dimers (Matsumoto et al., 2010; Bremm
et al., 2010), all TEK-box residues in the distal ubiquitin are fully
accessible for recognition by Ube2S.
The low affinity of Ube2S for the acceptor is in agreement with
observations for other E2s (Petroski and Deshaies, 2005; Ro-
drigo-Brenni et al., 2010) and likely protects cells from spurious
chain elongation in the absence of E3s. However, together with
our comparative docking analysis, the transient nature of
acceptor binding suggests that selective acceptor recognition
does not explain the linkage specificity of Ube2S.
Indeed, our model of the ternary complex between Ube2S,
donor, and acceptor ubiquitin revealed that Ube2S lacks
a residue required for suppressing the pKa of the substrate
lysine. This function is instead provided by Glu34 of ubiquitin,
which is in direct proximity to Lys11. Mutation of Glu34 had
strong effects on the apparent kcat, but not the KM, of linkage
formation by Ube2S, supporting a role in catalysis. Other Lys
residues of ubiquitin do not have a suitably positioned acidic
residue when docked into the active site of Ube2S or display
features incompatible with catalysis (Figure S8). The same likely
applies to Lys residues of APC/C substrates, which may explain
why Ube2S is unable to promote chain initiation (Garnett et al.,
2009; Williamson et al., 2009). Thus, our findings suggest that
formation of a competent catalytic center requires residues of
Ube2S and ubiquitin, which only occurs when K11 of the
acceptor is exposed to the active site of Ube2S. We conclude
that linkage-specific chain assembly by Ube2S occurs through
substrate-assisted catalysis.
Do other E2 enzymes use similar mechanisms for ubiquitin
transfer? We found that noncovalent donor binding is a property
shared by E2s with different linkage specificity. Ube2R1 and
Ube2G2 also tether the donor ubiquitin for efficient catalysis,
but not for K48 specificity, and Ube2R1 uses a similar surface
on its UBC domain as Ube2S uses for donor recognition. In addi-
tion, the HECT-E3 Nedd4L binds E2-linked donor ubiquitin,
a feature required for rapid ubiquitin transfer to the catalytic
cysteine of the E3 (Kamadurai et al., 2009); the E3 RanBP2 binds
SUMO to restrict its conformational freedom (Reverter and Lima,
2005); and in some cases, a ubiquitin-binding domain can
promote E2-dependent ubiquitination reactions (Hoeller et al.,
2007). We, therefore, propose that noncovalent donor binding
is a general property of ubiquitination enzymes to increase the
processivity of substrate modification.
Other E2s may also use substrate-assisted catalysis for chain
assembly. Mms2-Ubc13 positions Glu64 of ubiquitin close to
the E2 active site, and mutation of this residue resulted in
a decrease of K63-linkage formation (Eddins et al., 2006).
Thus, although acceptor binding to Mms2 helps to orient
Lys63 toward the active site of Ubc13, a catalytic ubiquitin
residue might increase the specificity of chain formation. More-
over, mutation of a Tyr residue in ubiquitin reduced the catalytic
rate of K48-linkage formation by yeast Ubc1 (Rodrigo-Brenni
et al., 2010). Together, these findings allow us to propose
that several E2 enzymes achieve linkage-specific ubiquitin
chain formation through a mechanism of substrate-assisted
catalysis.Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc. 779
EXPERIMENTAL PROCEDURES
A detailed methods description can be found in the Extended Experimental
Procedures.
Reagents
Table S4 shows a complete list of all constructs.
Protein Purification
Most proteinswere purified fromBL21/DE3 (RIL) cells. E1was purified fromSf9
cells. For uniform isotopic enrichment, Ube2S and ubiquitin were expressed in
M9-medium using 15N-enriched (NH4)2SO4 and/or
13C-enriched glucose.
To generate ester-linked complex, 75 mM 15N-enriched UBCUbe2S/C95S and
230 mM unlabeled ubiquitin were incubated at 37C for 3 hr. The diluted reac-
tion was subjected to two rounds of anion-exchange chromatography.
Formation of ubi2
60 mM ubiquitin and/or ubiDGG and 5 mM E2s were incubated with E1 and
energy mix at 30C for 1 hr and analyzed by Coomassie or Silver staining. In
assays comparing activity at different pH, Tris/HCl was replaced with 50 mM
Bis-tris propane, pH 7.5, 8, or 9.
Ube2S Kinetics Assays
Time courses of ubi2 formation were performed with different concentrations
of WT- or E34Q-ubiquitin. Levels of ubi2 were quantified by Quantity One
and compared to a known amount of Ube2S on each gel. Initial velocity rates
and kinetic constants were calculated with GraphPad Prism and Michaelis-
Menten equations.
APC/C Ubiquitination Assays
35S substrates were synthesized by IVT/T. Ub-L-cycA was synthesized in the
presence of 175 mMubiK29R to inhibit the UFD-pathway, which is active in retic-
ulocyte lysate. To purify 35S-Ub-L-cycA, HisCdk2 was bound to NiNTA. IVT/T
was added to beads for 3 hr at 4C. Beads were eluted with imidazole, and
Ub-L-cycA/Cdk2-complexes were concentrated with 30 MWCO Microcon
filters. APC/C was purified from G1-HeLa extracts and used for ubiquitination
as described (Rape et al., 2006).
Analysis of Ube2S Activity In Vivo
HeLa cells were transfected in 6-well plates with 4 mg Ube2S vectors and
Lipofectamine 2000. Twenty-four hours later, 10% of transfected cells were
expanded to 10 cm dishes and selected with hygromycin B. Individual
hygromycin-resistant colonies were picked with cloning discs and tested for
Ube2S expression by western.
Cells expressing Ube2S or mutants were transfected with 100 nM siRNA
with Oligofectamine and synchronized in prometaphase by thymidine/noco-
dazole. Samples were taken at 0 hr and 2 hr post-release and processed for
aK11-western.
Computational Docking
Donor docking was performed with HADDOCK 2.1, using crystal structures of
UBCUbe2S (Protein Data Bank (PDB) ID: 1ZDN, chain A) and ubiquitin (PDB ID:
1UBQ). Active residues were based on chemical shift perturbation data and
solvent accessibility. For thioester linkagebetweendonorandUbe2S,weapplied
an unambiguous intermolecular distance restraint between C95 of Ube2S and
G76 of ubiquitin. Residues 70–76 of ubiquitin were defined fully flexible.
To generate a model of the ternary complex, we docked a second ubiquitin
onto the selected E2-donor complex (cluster 1, no. 3; Table S1). We initially
applied a single unambiguous restraint between K11 of the acceptor and
C95 of Ube2S (Table S2, top), followed by a refined run with ambiguous
restraints based on functional data (Table S2).
Additional donor-docking experiments used ClusPro 2.0 and default
parameters.
NMR
Data were recorded at 25C on Bruker DRX spectrometers (500, 600, 800, and
900 MHz) and processed with NMRPipe. Backbone chemical shift assign-780 Cell 144, 769–781, March 4, 2011 ª2011 Elsevier Inc.ments for UBCUbe2S and ubiquitin were obtained by standard triple resonance
experiments. Titration experiments were performed by mixing stock solutions
containing 240 mM 15N-enriched UBCUbe2S or 200 mM 15N-enriched ubiquitin
and no or an 6-fold molar excess of unlabeled partner. Phase-sensitive
gradient-enhanced 1H-15N HSQC spectra were recorded. To compare
chemical shift perturbations, a weighted combined chemical shift difference
Dd(1H15N) was calculated.
1H-15N HSQC experiments of ester-linked complex between 15N-enriched
UBCUbe2S/C95S and ubiquitin were recorded with 22 mM complex.
ACCESSION NUMBERS
The 1H, 15N, and 13C backbone chemical shift assignments for Ube2S
(1–156) and ubiquitin have been submitted to the Biological Magnetic Reso-
nance Bank (BMRB), http://www.bmrb.wisc.edu, with accession numbers
17437 and 17439, respectively.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, eight
figures, and four tables and can be foundwith this article online at doi:10.1016/
j.cell.2011.01.035.
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